Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations

被引:2
|
作者
McGuire, Kandace P. [1 ]
Arthur, Douglas W. [1 ]
Mamounas, Eleftherios P. [2 ]
机构
[1] VCU Massey Canc Ctr, Richmond, VA 23298 USA
[2] Orlando Hlth Canc Inst, Orlando, FL USA
关键词
OLAPARIB; CHEMOTHERAPY; SURVIVAL;
D O I
10.1245/s10434-022-12048-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:6504 / 6507
页数:4
相关论文
共 50 条
  • [1] Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations
    Kandace P. McGuire
    Douglas W. Arthur
    Eleftherios P. Mamounas
    Annals of Surgical Oncology, 2022, 29 : 6504 - 6507
  • [2] BRCA Mutations and PARP Inhibitors in Breast and/or Ovarian Cancer Patients
    Gari, Abdulrahim
    Rawas, Ghufran
    Mufti, Ahmad
    Elemam, Omima
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2021, 10 (03): : 33 - 49
  • [3] PARP inhibitors for hereditary breast cancer with germline BRCA mutation
    Im, Seock-Ah
    ANNALS OF ONCOLOGY, 2022, 33 : S423 - S423
  • [4] PARP Inhibitors in Breast Cancer: BRCA and Beyond
    Rios, Jorge
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2011, 25 (11): : 1014 - 1025
  • [5] Hereditary Breast Cancer BRCA Mutations and Beyond
    Patel, Miral M.
    Adrada, Beatriz Elena
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2024, 62 (04) : 627 - 642
  • [6] PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival
    Shao, Fengping
    Duan, Yaoyun
    Zhao, Yunhe
    Li, Yinguang
    Liu, Jun
    Zhang, Cai
    He, Shanyang
    AGING-US, 2021, 13 (06): : 8975 - 8988
  • [7] PARP Inhibitors in Triple-Negative Breast Cancer Including Those With BRCA Mutations
    Layman, Rachel M.
    Arun, Banu
    CANCER JOURNAL, 2021, 27 (01): : 67 - 75
  • [8] Mutations of BRCA genes in hereditary breast and ovarian cancer
    Radice, P
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (03) : 9 - 12
  • [9] BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer
    Pristauz G.
    Geigl J.B.
    Petru E.
    Wiener Medizinische Wochenschrift, 2010, 160 (7-8) : 158 - 162
  • [10] Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer
    Pruthi, Sandhya
    Gostout, Bobbie S.
    Lindor, Noralane M.
    MAYO CLINIC PROCEEDINGS, 2010, 85 (12) : 1111 - 1120